Informatie:
Fout:
ID
25886
Beschrijving
A 24 week double-blind, randomised, placebo-controlled, parallel-group dose-ranging study to investigate the effects of rosiglitazone (extended release tablets) on cognition in subjects with mild to moderate Alzheimer's disease.
Trefwoorden
Versies (1)
- 25-09-17 25-09-17 -
Houder van rechten
Glaxo Smith Kline
Geüploaded op
25 september 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
GSK AVA100193 Rosiglitazone in Alzheimer´s Disease - Pharmacogenetic and Pharmacogenomic Research
Pharmacogenetic and Pharmacogenomic Research
- StudyEvent: ODM
Similar models
Pharmacogenetic and Pharmacogenomic Research
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
PGx-Pharmacogenetic/PGm-Transcriptomic/PGM-Proteomic Research
C2347501 (UMLS CUI-1)
C1327760 (UMLS CUI-2)
C1327760 (UMLS CUI-2)
Informed Consent
Item
Has informed consent been obtained for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic Research?
boolean
C0021430 (UMLS CUI [1])
Date informed consent obtained
Item
If Yes, record the date informed consent obtained for PGxPharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research
date
C0011008 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,2])
Item
If No, check
integer
C0392360 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C1882120 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,2])
C1882120 (UMLS CUI [1,3])
CL Item
Subject declined (1)
CL Item
Subject not asked by Investigator (2)
CL Item
Other (3)
reason informed consent not obtained
Item
If other reason please specify
text
C3845569 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C1882120 (UMLS CUI [1,3])
C0021430 (UMLS CUI [1,2])
C1882120 (UMLS CUI [1,3])
Blood sample collection
Item
Has a blood sample been collected for PGx-pharmacogenetic research?
boolean
C0005834 (UMLS CUI [1])
Blood sample collection date
Item
If Yes, record the date sample taken
date
C0005834 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
Withdrawal of Consent
Item
Has subject withdrawn consent for PGx-Pharmacogenetic/PGm-Transcriptomic/PGm-Proteomic research?
boolean
C1707492 (UMLS CUI [1,1])
C2347501 (UMLS CUI [1,2])
C1327760 (UMLS CUI [1,3])
C2347501 (UMLS CUI [1,2])
C1327760 (UMLS CUI [1,3])
Blood sample destruction
Item
Has a request been made for sample destruction?
boolean
C1948029 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,2])
Item
If Yes, check one reason
text
C1948029 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
C0178913 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
CL Item
Subject requested (1)
CL Item
Other (Z)
Other reason for sample destruction
Item
Other reason for sample destruction
text
C1948029 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
C3845569 (UMLS CUI [1,3])
C0178913 (UMLS CUI [1,2])
C3845569 (UMLS CUI [1,3])